Summit Street Capital Management, LLC Myriad Genetics Inc Transaction History

Summit Street Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $810,512 - $1.04 Million	-30,097 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $3.29 Million - $4.68 Million	-114,000 Reduced 79.11%	30,097 $889,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $198,751 - $259,460	6,986 Added 5.1%	144,097 $4.95 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $3.29 Million - $4.96 Million	137,111	137,111 $4.96 Million

192

94.2M

280K

14.3K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.04B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Summit Street Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Street Capital Management, LLC with notifications on news.